Dr. Robert Coleman is the Chief Medical Officer at the Vaniam Group.  He was previously at US Oncology Research as its Chief Scientific Officer,  and  previously served as the Ann Rife Cox Chair in Gynecology and a professor in the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center (MDACC), as well as executive director for MDACC’s Cancer Network Research Program. He is also a member of the board of directors for the Gynecologic Oncology Group (GOG) Foundation and co-director of GOG Partners.  Dr. Coleman won the Rosalind Franklin Excellence in Ovarian Cancer Research Award (2018) and is a past president of the Society for Gynecologic Oncology (2015). He is the current president of the International Gynecologic Cancer Society. In 2020 Dr. Coleman was included in the top 15 Giants in Cancer Care program recognition program which celebrates the achievements of leading researchers and educators whose discoveries have helped propel the field forward and established the building blocks for future advances.